Human coffee drinking: reinforcing and physical dependence producing effects of caffeine
- PMID: 3772801
Human coffee drinking: reinforcing and physical dependence producing effects of caffeine
Abstract
In a residential research ward coffee drinking was studied in nine volunteer human subjects with histories of heavy coffee drinking. The presence or absence of caffeine in the coffee was manipulated under double-blind conditions by using caffeinated (C) or decaffeinated (D) coffee. When subjects were switched alternately for 10 or more consecutive days between C and D, the daily number of cups consumed tended to be relatively stable. In a different experiment, preference for C vs. D was assessed. After experimenter-scheduled exposures, subjects were given choices between C and D. When subjects were presumably caffeine tolerant/dependent, C was rated as being better liked than D and was reliably preferred to D in choice tests. When subjects were not caffeine tolerant/dependent, C was not reliably preferred to D, nor were there pronounced differences in ratings of liking. Under these conditions, some subjects preferred D to C, citing adverse symptoms (suggesting caffeine toxicity) as reasons for avoiding C. The effects of caffeine withdrawal were studied by abruptly substituting D for C for 10 or more days. This resulted in an orderly withdrawal syndrome, having an onset latency of 19 hr, peaking on days 1 and 2, and decreasing progressively over the next 5 or 6 days. The withdrawal syndrome, which was detected on subject-rated, staff-rated and objective behavioral measures, was characterized by increased headache, sleepiness and laziness and decreased alertness and activeness. The present study demonstrates the reinforcing effects of caffeine in humans and also documents the severity of the caffeine withdrawal syndrome. It is concluded that caffeine has the cardinal features of a prototypic drug of abuse.
Similar articles
-
Reinforcing effects of caffeine in coffee and capsules.J Exp Anal Behav. 1989 Sep;52(2):127-40. doi: 10.1901/jeab.1989.52-127. J Exp Anal Behav. 1989. PMID: 2794839 Free PMC article. Clinical Trial.
-
Low-dose caffeine physical dependence in humans.J Pharmacol Exp Ther. 1990 Dec;255(3):1123-32. J Pharmacol Exp Ther. 1990. PMID: 2262896 Clinical Trial.
-
Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 Nov;20(5):223-31. Nihon Shinkei Seishin Yakurigaku Zasshi. 2000. PMID: 11326548 Review.
-
Caffeine abstinence: an ineffective and potentially distressing tinnitus therapy.Int J Audiol. 2010 Jan;49(1):24-9. doi: 10.3109/14992020903160884. Int J Audiol. 2010. PMID: 20053154 Clinical Trial.
-
Teratogen update: evaluation of the reproductive and developmental risks of caffeine.Teratology. 2001 Jul;64(1):51-78. doi: 10.1002/tera.1047. Teratology. 2001. PMID: 11410911 Review.
Cited by
-
Caffeine and health.Br Med J (Clin Res Ed). 1987 Nov 21;295(6609):1293-4. doi: 10.1136/bmj.295.6609.1293. Br Med J (Clin Res Ed). 1987. PMID: 3120982 Free PMC article. Review. No abstract available.
-
Overnight caffeine abstinence and negative reinforcement of preference for caffeine-containing drinks.Psychopharmacology (Berl). 1995 Aug;120(4):457-62. doi: 10.1007/BF02245818. Psychopharmacology (Berl). 1995. PMID: 8539327
-
Caffeine reinforces flavour preference in caffeine-dependent, but not long-term withdrawn, caffeine consumers.Psychopharmacology (Berl). 2003 Apr;166(4):416-23. doi: 10.1007/s00213-002-1354-1. Epub 2003 Feb 13. Psychopharmacology (Berl). 2003. PMID: 12589525 Clinical Trial.
-
The role of nicotine in tobacco use.Psychopharmacology (Berl). 1992;108(4):397-407. doi: 10.1007/BF02247412. Psychopharmacology (Berl). 1992. PMID: 1410152 Review.
-
A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.Psychopharmacology (Berl). 2004 Oct;176(1):1-29. doi: 10.1007/s00213-004-2000-x. Epub 2004 Sep 21. Psychopharmacology (Berl). 2004. PMID: 15448977 Review.